pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID: c1ab67f7-67b1-4c57-a327-49e8e2a497bc
Type: Q1 — 1st Quarter - Report
Period: first_quarter
Year: 2026
Posted: 2026-04-17 14:42:43
Income (reported): —
Expenses (reported): $210,000
Expenses method: A
Filing document: Open on lda.senate.gov

Registrant (lobbying firm)

OTSUKA AMERICA PHARMACEUTICAL, INC.

Pharmaceutical research and development

Contact: AMELIA SUERMANN
Phone: +1 202-997-6592
Address: zip:20850, city:Rockville, state:MD, street:2440 Research Drive

Client

OTSUKA AMERICA PHARMACEUTICAL, INC.

State: MD
Country: US
Government-entity client: false
Effective date: 2021-04-20

Issues lobbied + lobbyists

`MMM` — Medicare/Medicaid

Implementation of the Inflation Reduction Act. Issues related to Medicare Part D redesign's impact on low-income subsidy beneficiaries.

Lobbyists: AMELIA SUERMANN; THOMAS FOULKES; ISABEL OMER [new]

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

`HCR` — Health Issues

Issues relating to early detection of PTSD, mental health parity and coordinated care and mental health equity. PBM reform. Issues related to rare nephrology/kidney diseases, 340B reform, psychedelics treatments for PTSD and mental health. H.R. 1518, the New Era of Preventing End-Stage Kidney Disease Act. Issues related to drug pricing, foreign reference pricing, biomedical research, and pharmaceutical supply chain.

Lobbyists: AMELIA SUERMANN; THOMAS FOULKES; ISABEL OMER [new]

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

`BUD` — Budget/Appropriations

Appropriations for the Department of Health & Human Services, the Department of Veterans Affairs, and the Department of Defense.

Lobbyists: AMELIA SUERMANN; THOMAS FOULKES; ISABEL OMER [new]

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

`VET` — Veterans

Health care policies relating to mental health and PTSD, including authorizations and appropriations for the Department of Veterans Affairs related to mental health and PTSD.

Lobbyists: AMELIA SUERMANN; THOMAS FOULKES [new]; ISABEL OMER [new]

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

`TAR` — Tariff (miscellaneous tariff bills)

Issues related to tariffs on pharmaceuticals and pharmaceutical supply chain.

Lobbyists: AMELIA SUERMANN; THOMAS FOULKES; ISABEL OMER [new]

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.

Estimated value: $180/mo per user — but we made it free.

Want to partner? Contact us.